Breaking News, Collaborations & Alliances

Cesca Therapeutics, HealthBanks Biotech Form Cell-Based CDMO JV

To commercialize its cell processing platform, CAR-TXpress, for use in immune cell banking and cell-based contract development and manufacturing services

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Cesca Therapeutics Inc., a provider of automated cell processing and autologous cell therapies for regenerative medicine, and ThermoGenesis, its device subsidiary, has entered into a joint venture with HealthBanks Biotech (USA) Inc., a leading stem cell bank network, to commercialize its cell processing platform, CAR-TXpress, for use in immune cell banking and cell-based contract development and manufacturing services. The joint venture will be named ImmuneCyte Life Sciences Inc. and is expected...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters